How are osteoclasts induced to resorb bone?

Annals of the New York Academy of Sciences

Volumn 1240, Issue 1, 2011, Pages 1-6

  Chambers, T J ^a   Fuller, K ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bone resorption; Osteoclast; Podosome belt; Vitronectin

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN; FIBRONECTIN; OSTEOPONTIN; THROMBOSPONDIN; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN; VITRONECTIN RECEPTOR;

BONE DEMINERALIZATION; BONE MINERAL; CELL ADHESION; CELL STRUCTURE; INTRACELLULAR SIGNALING; MATERIAL COATING; MOLECULAR RECOGNITION; NOTE; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOLYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR AFFINITY;

EID: 83755186547     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06249.x     Document Type: Note

References (50)

1. Stenbeck, G. 2002. Formation and function of the ruffled border in osteoclasts. Semin. Cell. Dev. Biol. 13: 285-292.
2. Vaananen, H.K., H. Zhao, M. Mulari & J.M. Halleen. 2000. The cell biology of osteoclast function. J. Cell. Sci. 113: 377-381.
3. Chambers, T.J., B.M. Thomson & K. Fuller. 1984. Effect of substrate composition on bone resorption by rabbit osteoclasts. J. Cell Sci. 70: 61-71.
4. Chambers, T.J. & T.J. Hall. 1991. Cellular and molecular mechanisms in the regulation and function of osteoclasts. Vitam. Horm. 46: 41-86.
5. Chow, J. & T.J. Chambers. 1992. An assessment of the prevalence of organic material on bone surfaces. Calcif. Tissue Int. 50: 118-122.
6. Chambers, T.J. & K. Fuller. 1985. Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J. Cell Sci. 76: 155-165.
7. Chambers, T.J., J.A. Darby & K. Fuller. 1985. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res. 241: 671-675.
8. Fuller, K. & T.J. Chambers. 1995. Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J. Cell Sci. 108: 2221-2230.
9. Delaisse, J.M., A. Boyde, E. Maconnachie, et al. 1987. The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 8: 305-313.
10. Fuller, K., B. Kirstein & T.J. Chambers. 2007. Regulation and enzymatic basis of bone resorption by human osteoclasts. Clin. Sci. (London) 112: 567-575.
11. Saltel, F., O. Destaing, F. Bard, et al. 2004. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol. Biol. Cell 15: 5231-5241.
12. Fisher, J.E., M.P. Caulfield, M. Sato, et al. 1993. Inhibition of osteoclastic bone-resorption in vivo by echistatin, an arginyl-glycyl-aspartyl (rgd)-containing protein. Endocrinology 132: 1411-1413.
13. Lakkakorpi, P.T., M.A. Horton, M.H. Helfrich, et al. 1991. Vitronectin receptor has a role in bone-resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J. Cell Biol. 115: 1179-1186.
14. Engelman, V.W., G.A. Nickols, F.P. Ross, et al. 1997. A peptidomimetic antagonist of the alpha(v)beta(3) integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J. Clin. Invest. 99: 2284-2292.
15. Chambers, T.J., K. Fuller, J.A. Darby, et al. 1986. Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Miner. 1: 127-135.
16. Horton, M.A., M.L. Taylor, T.R. Arnett & M.H. Helfrich. 1991. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp. Cell Res. 195: 368-375.
17. Fuller, K., J.L. Ross, K.A. Szewczyk, et al. 2010. Bone is not essential for osteoclast activation. PLoS One 5: e12837.
18. Fuller, K., B. Kirstein & T.J. Chambers. 2006. Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147: 1979-1985.
19. Kirstein, B., T.J. Chambers & K. Fuller. 2006. Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behavior. J. Cell Biochem. 98: 1085-1094.
20. Lakkakorpi, P.T. & H.K. Vaananen. 1990. Calcitonin, prostaglandin E2, and dibutyryl cyclic adenosine 3', 5'-monophosphate disperse the specific microfilament structure in resorbing osteoclasts. J. Histochem. Cytochem. 38: 1487-1493.
21. Burgess, T.L., Y. Qian, S. Kaufman, et al. 1999. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell Biol. 145: 527-538.
22. Jurdic, P., F. Saltel, A. Chabadel & O. Destaing. 2006. Podosome and sealing zone: specificity of the osteoclast model. Eur. J. Cell Biol. 85: 195-202.
23. Lakkakorpi, P.T., M.H. Helfrich, M.A. Horton & H.K. Vaananen. 1993. Spatial organization of microfilaments and vitronectin receptor, alpha v beta 3, in osteoclasts. A study using confocal laser scanning microscopy. J. Cell Sci. 104: 663-670.
24. Lakkakorpi, P.T. & H.K. Vaananen. 1996. Cytoskeletal changes in osteoclasts during the resorption cycle. Microsc. Res. Tech. 33: 171-181.
25. Luxenburg, C., D. Geblinger, E. Klein, et al. 2007. The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS One 2: e179.
26. Fuller, K., J.M. Owens, C.J. Jagger, et al. 1993. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med. 178: 1733-1744.
27. Geblinger, D., L. Addadi & B. Geiger. 2010. Nano-topograpy sensing by osteoclasts. J. Cell Sci. 123: 1503-1510.
28. Nakamura, I., N. Takahashi, T. Sasaki, et al. 1996. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. J. Bone Miner. Res. 11: 1873-1879.
29. Charo, I.F., L. Nannizzi, J.W. Smith & D.A. Cheresh. 1990. The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J. Cell Biol. 111: 2795-2800.
30. Hughes, D.E., D.M. Salter, S. Dedhar & R. Simpson. 1993. Integrin expression in human bone. J. Bone Miner. Res. 8: 527-533.
31. Lowe, C., T. Yoneda, B.F. Boyce, et al. 1993. Osteopetrosis in src-deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. U. S. A. 90: 4485-4489.
32. Boyce, B.F., T. Yoneda, C. Lowe, et al. 1992. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90: 1622-1627.
33. Horne, W.C., L. Neff, D. Chatterjee, et al. 1992. Osteoclasts express high-levels of pp60(c-src) in association with intracellular membranes. J. Cell Biol. 119: 1003-1013.
34. Arias-Salgado, E.G., S. Lizano, S. Sarkar, et al. 2003. SRC kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc. Natl. Acad. Sci. U. S. A. 100: 13298-13302.
35. Felsenfeld, D.P., P.L. Schwartzberg, A. Venegas, et al. 1999. Selective regulation of integrin-cytoskeleton interactions by the tyrosine kinase SRC. Nature Cell Biol. 1: 200-206.
36. Boskey, A.L., M. Maresca, W. Ullrich, et al. 1993. Osteopontin-hydroxyapatite interactions in-vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner. 22: 147-159.
37. Oldberg, A., A. Franzen & D. Heinegard. 1986. Cloning and sequence-analysis of rat bone sialoprotein (osteopontin) CDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc. Natl. Acad. Sci. U. S. A. 83: 8819-8823.
38. Huq, N.L., K.J. Cross & E.C. Reynolds. 2000. Molecular modelling of a multiphosphorylated sequence motif bound to hydroxyapatite surfaces. J. Mol. Modeling 6: 35-47.
39. Robey, P.G., M.F. Young, L.W. Fisher & T.D. McClain. 1989. Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix. J. Cell Biol. 108: 719-727.
40. Bianco, P., L.W. Fisher, M.F. Young, et al. 1991. Expression of bone sialoprotein (BSP) in developing human tissues. Calc. Tiss. Intl. 49: 421-426.
41. Dodds, R.A., J.R. Connor, I.E. James, et al. 1995. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone. J. Bone Miner. Res. 10: 1666-1680.
42. Arai, N., K. Ohya, S. Kasugai, et al. 1995. Expression of bone sialoprotein messenger-RNA during bone-formation and resorption induced by colchicine in rat tibial bone-marrow cavity. J. Bone Miner. Res. 10: 1209-1217.
43. Tezuka, K., T. Sato, H. Kamioka, et al. 1992. Identification of osteopontin in isolated rabbit osteoclasts. Biochem. Biophys. Res. Comm. 186: 911-917.
44. Boyd, N.A., A.R. Bradwell & R.A. Thompson. 1993. Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice. J. Clin. Pathol. 46: 1042-1045.
45. Shaffer, M.C., T.P. Foley & D.W. Barnes. 1984. Quantitation of spreading factor in human biologic fluids. J. Lab. Clin. Med. 103: 783-791.
46. Schmidt, S., I. Nakchbandi, R. Ruppert, et al. 2011. Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption. J. Cell Biol. 192: 883-897.
47. McHugh, K.P., K. Hodivala-Dilke, M.H. Zheng, et al. 2000. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105: 433-440.
48. Helfrich, M.H., S.A. Nesbitt, P.T. Lakkakorpi, et al. 1996. Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone 19: 317-328.
49. Horton, M.A., H.M. Massey, N. Rosenberg, et al. 2003. Upregulation of osteoclast alpha2beta1 integrin compensates for lack of alphavbeta3 vitronectin receptor in Iraqi- Jewish-type Glanzmann thrombasthenia. Br. J. Haematol. 122: 950-957.
50. Koistinen, P. & J. Heino. 2002. The selective regulation of alpha Vbeta 1 integrin expression based on the hierarchical formation of alpha V-containing heterodimers. J. Biol. Chem. 277: 24835-24841.